APA (7th ed.) Citation

Khemichian, S., Hsieh, M., Zhang, S., Limurti, J., Kim, J., & Fong, T. (2015). Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation. Digestive Diseases & Sciences, 60(9), 2807. https://doi.org/10.1007/s10620-015-3671-3

Chicago Style (17th ed.) Citation

Khemichian, Saro, Mary Hsieh, Shi-Rong Zhang, Joyce Limurti, John Kim, and Tse-Ling Fong. "Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation." Digestive Diseases & Sciences 60, no. 9 (2015): 2807. https://doi.org/10.1007/s10620-015-3671-3.

MLA (9th ed.) Citation

Khemichian, Saro, et al. "Nucleoside-Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation." Digestive Diseases & Sciences, vol. 60, no. 9, 2015, p. 2807, https://doi.org/10.1007/s10620-015-3671-3.